Offering onsite COVID-19 vaccination to high-risk obstetrical patients: initial findings

Medicine and Dentistry

• COVID-19 Vaccination 100%
• Uptake Rates 100%
• Vaccine Hesitancy 100%
• Counseling 50%
• Virus Infection 50%
• Patient Population 50%
• Perinatology 50%
• COVID-19 50%
• Quality Improvement 25%
• Clinician 25%
• Decision Making 25%
• Population Research 25%
• Outpatient 25%
• High Risk Population 25%
• Early Intervention 25%
• Severe Acute Respiratory Syndrome Coronavirus 2 25%
• RNA Immunization 25%
• Messenger RNA 25%
• Diseases 25%

Keyphrases

• High Risk 100%
• Vaccination 100%
• COVID-19 Vaccination 100%
• Uptake Rate 20%
• Vaccine Hesitancy 20%
• Counseling 15%
• Missouri 15%
• Clinic Visits 15%
• Pregnant Women 15%
• Vaccine Uptake 15%
• Vaccination Rate 15%
• Patient Demographics 10%
• Maternal-fetal Medicine 10%
• Illinois 10%
• Vaccine Availability 10%
• Vaccine Access 10%
• Early Intervention 5%
• Novel Therapeutics 5%
• During Pregnancy 5%
• Obstetricians 5%
• Highly Effective 5%
• Viral Infection 5%
• Academic Medical Centers 5%
• Viral Disease 5%
• Clinical Setting 5%
• Expanded Access 5%
• Messenger RNA (mRNA) 5%
• Disease Prevention 5%
• Centers for Disease Control 5%
• At-risk 5%
• Rapport 5%
• Non-Hispanic Black Women 5%
• High-risk Population 5%
• Large Sample Size 5%
• Rapidly Evolving 5%
• Insurance 5%
• Outpatient Clinic 5%
• American Colleges 5%
• COVID-19 Pandemic 5%
• Patient Charts 5%
• Low Uptake 5%
• Vaccine Trial 5%
• Gynecologist 5%
• Patient Views 5%
• Expert Clinician 5%
• Qualifying Conditions 5%
• Immediately Available 5%
• Quality Improvement Project 5%
• Vaccine Administration 5%
• Vaccination Recommendation 5%
• State Database 5%
• Sources of Bias 5%
• External Sites 5%
• SARS-CoV-2 Transmission 5%
• Personal Reasons 5%
• Severe COVID-19 5%
• BNT162b2 5%
• Local Area 5%
• Disproportionate Impact 5%
• Office for Human Research Protections 5%
• Post-nature 5%
• Discussion Platforms 5%
• Critical Drivers 5%
• RNA Vaccination 5%
• Vaccination Dose 5%
• Low Vaccination Rates 5%
• Vaccine Decision-making 5%
• COVID-19 Vaccination Uptake 5%